Advertisement
Guest User

D&C oxycotin rainbowdash.net

a guest
Apr 23rd, 2012
141
0
Never
Not a member of Pastebin yet? Sign Up, it unlocks many cool features!
text 1.80 KB | None | 0 0
  1. Dear Website Owner,
  2.  
  3. For many years, Purdue L.P. (“Purdue”) has been selling preparations for the relief of pain under its well-known trademark OxyContin®. Because of Purdue’s extensive use of its OxyContin trademark, consumers and the trade have come to identify products offered under this trademark as indicating a product that is authorized by Purdue. Purdue is the owner of the following registrations in the United States Patent and Trademark Office:
  4.  
  5. Mark Registration/Serial No. Date of Registration
  6. OXYCONTIN® 2,004,586 10/1/96
  7. OXYCONTIN® 2,033,914 11/5/96
  8.  
  9. It has come to our attention that our trademark OxyContin appears as a trademark, metatag, keyword, visible or hidden text on the website(s) located at: rainbowdash.net without having obtained prior written authorization from Purdue.
  10.  
  11. http://rainbowdash.net/oxycontin
  12.  
  13. In view of Purdue's rights to the trademark OxyContin, and in order to avoid confusion that your website originates with or is authorized by, sponsored by, or in some way connected with Purdue, we request that you immediately remove all trademarks, metatags, keywords, visible or hidden text presently appearing on the above-cited website(s) and any other website(s) that include the term OxyContin.
  14.  
  15. You should also be aware that any unlawful distribution of controlled substances such as OxyContin via the Internet would be in violation of the Controlled Substances Act, Title 21 United States Code (U.S.C.). Violations are punishable under 21 U.S.C. Section 841.
  16.  
  17. Should you require additional information or wish to further discuss this issue, please do not hesitate to contact the undersigned.
  18.  
  19.  
  20. Sincerely,
  21.  
  22. Purdue Pharma LP
  23.  
  24. brandprotection@mm-purduepharma.com
Advertisement
Add Comment
Please, Sign In to add comment
Advertisement